Are virus-induced cancers more sensitive to checkpoint inhibitors? - Wikidata - awgldk - TriplyDB

Are virus-induced cancers more sensitive to checkpoint inhibitors?

Are virus-induced cancers more sensitive to checkpoint inhibitors?

http://www.wikidata.org/entity/Q38832379

about

Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanoma.A Review of Immune Therapy in Cancer and a Question: Can Thermal Therapy Increase Tumor Response?The second wave of immune checkpoint inhibitor tsunami: advance, challenges and perspectives.

P2860

Q38741789-B23D2503-1A22-4931-A26E-03172E0AA503 Q41928232-2F23650D-3047-4C17-90F1-9F66F4CF99C1 Q50921394-6F4551EE-A626-42B4-A4FC-D3E2D2ED40D8

P2860

Are virus-induced cancers more sensitive to checkpoint inhibitors?

http://www.wikidata.org/entity/Q38832379

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Are virus-induced cancers more sensitive to checkpoint inhibitors?

@en

type

label

Are virus-induced cancers more sensitive to checkpoint inhibitors?

@en

prefLabel

Are virus-induced cancers more sensitive to checkpoint inhibitors?

@en

P1433

Q38832379-7BBFE544-9AF9-441A-97F3-27A055895011

P1476

Q38832379-0E2CF631-2AC1-42DC-AD62-51F3146133C0

P2093

Q38832379-0820E9F1-69CF-4BAF-B8C1-6C997167DC5A

Q38832379-414BB162-DCE9-40ED-8001-BC9369201D7D

Q38832379-C60A8B79-5E3A-4787-8993-432EF6A188B3

P2860

Q38832379-0DCE6002-23A7-4409-BBF9-03B180CBB616

Q38832379-16A3D2C6-C3E3-4178-BD7E-C1073F111911

Q38832379-2D58CE9A-B8F2-4EF9-A0E6-D24FD50335C7

Q38832379-39376611-B2E7-459A-B261-7B2634E9E6D1

Q38832379-3C015651-83B3-4BC1-A95E-9E6BBE3601C4

Q38832379-6607C035-14F1-475C-B302-B65E18843E91

Q38832379-70820163-5F13-4C39-A830-DDD3DC862F4A

Q38832379-7BB7BE1B-F106-43B7-ADFF-B17FEAE74248

Q38832379-8527A638-A2D9-4C95-9FA1-791FC82D1D72

Q38832379-8C393026-26A1-45ED-BD0E-58E89588F046

P304

Q38832379-0660D438-B353-4EA7-AAE4-9E711A4DA60F

P31

Q38832379-51358B2D-68A5-4D63-ACAA-55703CC5998C

P356

Q38832379-C85EAA12-5851-4A2C-B6C8-1D49877653FB

P407

Q38832379-06EF5DB2-8E7A-4AA6-BBFC-D7474A0DC357

P433

Q38832379-9643B093-050A-44CA-8D39-D8F2CA859F1C

P478

Q38832379-C7AE3EAE-DE21-4EE6-8942-DE399A84E36F

P577

Q38832379-8B442AAE-EFDF-4D71-AFAD-BFCD773B1A6E

P698

Q38832379-62E019F8-23D9-4571-9A2D-CCDD7F752FCE

P356

P1433

Future Oncology

P1476

Are virus-induced cancers more sensitive to checkpoint inhibitors?

@en

P2093

Ahmad Hussein Awada

http://www.w3.org/2001/XMLSchema#string

Hampig Raphael Kourie

http://www.w3.org/2001/XMLSchema#string

Hassan Kanaan

http://www.w3.org/2001/XMLSchema#string

P2860

Viruses associated with human cancer

Comprehensive molecular characterization of gastric adenocarcinoma

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities.

Neoantigens in cancer immunotherapy.

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.

Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy.

PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival.

Human viral oncogenesis: a cancer hallmarks analysis

P304

2665-2668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2016-0283

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27513334

http://www.w3.org/2001/XMLSchema#string